Warburg revisited: imaging tumour blood flow and metabolism
Open Access
- 1 January 2008
- journal article
- review article
- Published by E-MED LTD in Cancer Imaging
- Vol. 8 (1) , 81-86
- https://doi.org/10.1102/1470-7330.2008.0011
Abstract
Warburg revisited: imaging tumour blood flow and metabolism - Cancer Imaging Warburg revisited: imaging tumour blood flow and metabolism - In the 1930s, Otto Warburg reported that anaerobic metabolism of glucose is a fundamental property of all tumours, even in the presence of an adequate oxygen supply. He also demonstrated a relationship between the degree of anaerobic metabolism and tumour growth rate. Today, this phenomenon forms the basis of tumour imaging with fluorodeoxyglucose positron emission tomography (FDG-PET).Keywords
This publication has 34 references indexed in Scilit:
- Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancerNature Medicine, 2005
- Blood flow–metabolic relationships are dependent on tumour size in non-small cell lung cancer: a study using quantitative contrast-enhanced computer tomography and positron emission tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2005
- Assessment of the tumor microenvironment in cervix cancer using dynamic contrast enhanced CT, interstitial fluid pressure and oxygen measurementsInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor.2005
- Energy Boost: The Warburg Effect Returns in a New Theory of CancerJNCI Journal of the National Cancer Institute, 2004
- Relationships between oxygen and glucose metabolism in human liver tumours: positron emission tomography using 15O and 18F-deoxyglucoseNuclear Medicine Communications, 2004
- Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancerNature Medicine, 2004
- To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT.2004
- Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2003
- Using Positron Emission Tomography 2-Deoxy-2-[18F]Fluoro-D-Glucose, 11CO, and 15O-Water for Monitoring Androgen Independent Prostate CancerMolecular Imaging & Biology, 2003